Acifer Complex
Acifer Complex, licence 80069929: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Holi-fer
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80069929
- Status
- Active licence
- Licence date
- 3 June 2016
- Revision date
- 11 June 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Fer: up to 60 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Fer: up to 60 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSAEuropean Food Safety Authority. for adults (40 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Fumarate de fer (II) | 60.0 milligramme | 60,000 µg |
| Folate Source : Acide folique | 800.0 microgrammes | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Eau purifiée, Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Helps to form red blood cells and helps in their proper function. Helps to prevent iron deficiency anaemia. Helps the body to metabolize proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. There is enough drug in this package to seriously harm a child. Folate supplementation can mask a vitamin B12 deficiency. If you are unsure whether you are taking enough vitamin B12, consult a physician prior to use. Prolonged use of high dose iron beyond the correction of the iron deficiency is not recommended and may result in iron overload. Use only upon recommendation by a physician. Prolonged use of high levels of iron without evidence of iron deficiency will result in iron overload causing a darkening of the skin, joint and bone pain, sexual dysfunction and/or multiple organ damage. Discontinue use and consult your physician if you experience abdominal pain/soreness or the presence of blood in the stool, this product may aggravate existing peptic ulcer or other inflammatory conditions of the gastrointestinal tract. If you are also taking a prenatal supplement (likely to contain significant amounts of iron and folate), the total daily dose of iron and folate should be considered. Some people may experience constipation, diarrhea, and/or vomiting. Do not use except under the care of a physician. Do not use for a prolonged time unless instructed by physician. Consult a physician prior to use if you are pregnant or breastfeeding. Consult a physician prior to use if you have a peptic ulcer, regional enteritis and ulcerative colitis. Discontinue use and consult a physician if you experience symptoms of iron toxicity such as nausea, vomiting, abdominal pain, hematemesis (vomiting of blood), and diarrhea.
Source
Official Health Canada record, licence 80069929
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.